| The Efficacy and Safety of Radiotherapy Plus Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer (NCT05162196) | Wuhan University | 2022-06-01 |
| Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC (NCT04610658) | H. Lee Moffitt Cancer Center and Research Institute | 2020-11-23 |
| Anlotinib in Treatment of Recurrent Small Cell Lung Cancer (NCT03732846) | Peking University Cancer Hospital & Institute | 2018-11-01 |
| Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients (NCT01999881) | University of Wisconsin, Madison | 2013-12-01 |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers (NCT01935336) | University of Colorado, Denver | 2013-09-24 |
| Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer (NCT01901653) | Stemcentrx | 2013-07-01 |
| Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer (NCT01803269) | University of Chicago | 2013-01-16 |
| Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer (NCT01457469) | Wake Forest University Health Sciences | 2011-01-01 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258) | University of Southern California | 2010-06-01 |
| S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00828139) | National Cancer Institute (NCI) | 2009-05-01 |
| R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer (NCT00773955) | National Cancer Institute (NCI) | 2008-11-01 |
| Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors (NCT00521144) | National Cancer Institute (NCI) | 2007-08-01 |
| Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer (NCT00470054) | National Cancer Institute (NCI) | 2007-04-01 |
| Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer (NCT00182689) | National Cancer Institute (NCI) | 2005-07-01 |
| 7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer (NCT00098956) | National Cancer Institute (NCI) | 2005-01-01 |
| Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer (NCT00086827) | National Cancer Institute (NCI) | 2004-05-01 |
| Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy (NCT00084487) | National Cancer Institute (NCI) | 2004-04-01 |
| Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer (NCT00042978) | National Cancer Institute (NCI) | 2003-04-01 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
| Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors (NCT00028535) | National Cancer Institute (NCI) | 2001-11-01 |
| Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC) (NCT00168922) | Charite University, Berlin, Germany | 2001-02-01 |
| FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer (NCT00020202) | National Cancer Institute (NCI) | 2000-06-01 |